Citigroup
GDRX icon

Citigroup’s GoodRx Holdings GDRX Stock Holding History

Citigroup’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,000
Closed -$40K – 6669
2020
Q4 		$40K Buy
+1,000
New +$45.9K ﹤0.01% 6196

Other funds holding GDRX

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Technology Crossover Management X
Technology Crossover Management X Menlo Park, California $648M AUM 23.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup's GDRX Position: Q3 2026 in Review

Citigroup increased its GoodRx Holdings (GDRX) stake by 18% in Q3 2026, buying an estimated $8.3K and bringing the position to 16,476 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4683.

Citigroup first reported a position in GDRX in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.3M in Q1 2021. 83 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Citigroup held 16,476 shares of GoodRx Holdings worth $54.2K as of Q3 2026.
  • Citigroup bought 2,494 GoodRx Holdings shares in Q3 2026, an estimated $8.3K.
  • GoodRx Holdings made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4683 holding.
  • Citigroup first reported a position in GoodRx Holdings in Q4 2020 and has held it in 20 quarters since.
  • Citigroup's GoodRx Holdings position peaked at $5.3M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.